ArticleVirchows Archiv : an international journal of pathology2026
Histomorphologic spectrum and genetic features of esophageal carcinomas with submucosal gland differentiation.
Article in Virchows Archiv : an international journal of pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Submucosal gland differentiation (SGD), including acinar and ductal differentiation, has been detected in different subtypes of esophageal carcinoma, complicating tumor classification and diagnosis. This study aims to delineate the histomorphologic characteristics and to reveal the genetic alterations and precursor squamous dysplasia of the esophageal carcinomas with SGD. A panel of immunohistochemical markers was used to recognize and subcategorize the SGD. Next-generation sequencing (NGS) was performed on selected cases. Group 1 retrospectively included 50 pure type BSCCs with SGD. Group 2 included 25 carcinomas with ductal differentiation. In group 1, the integral branching morphology was observed in 20% (10/50) of cases without auxiliary immunohistochemical examination. The carcinomas from group 2 lacked integral branching morphology but exhibited recognizable to apparent ductal structures of different sizes, shapes, and proportions. The precursor squamous dysplasia was generally of the basaloid type. BSCCs with complete SGD showed positivity of both SOX9 and SOX10, while carcinomas with incomplete SGD (ductal differentiation) were positive for SOX9 but negative for SOX10. Carcinomas with SGD showed common gene mutations (TP53, TTN, and NOTCH1) and related signal pathways (TP53 and NOTCH pathways) of conventional SCCs. Two mutation signatures, which were highly similar to the COSMIC signatures 1, 6, and 13, were identified. Compared to the SCC groups, the tumor mutation burden (TMB) was slightly elevated, likely due to a high frequency of mutations of the TTN gene and defective DNA mismatch repair. In summary, the SGD can be separated into complete and incomplete types. Esophageal carcinomas with SGD mostly arise from the basaloid squamous dysplasia, and their genetic alterations align more closely with those of conventional SCCs.
Indexed as
Identifiers
41995820What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.